SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-015752
Filing Date
2020-08-14
Accepted
2020-08-14 13:40:06
Documents
1
Period of Report
2020-05-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1556
  Complete submission text file 0001493152-20-015752.txt   3242
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Issuer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 449 WEST NECK ROAD LLOYD HARBOR NY 11743
Business Address
Grainer James L (Reporting) CIK: 0001307915 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33635 | Film No.: 201103755